VIVUS Inc (NASDAQ:VVUS)

0.3621
Delayed Data
As of Apr 24
 -0.0179 / -4.71%
Today’s Change
0.33
Today|||52-Week Range
1.38
-27.95%
Year-to-Date

Today’s Trading

Previous close0.38
Today’s open0.38
Day’s range0.36 - 0.39
Volume336,277
Average volume (3 months)648,109
Market cap$51.9M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-245.45%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+30.21%
P/E ratioNM
Price/Sales0.97
Price/Book2.83

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc-0.03-2.68%
MEIPMEI Pharma Inc-0.12-5.50%
SYNSynthetic Biologics ...-0.02-7.56%
ZFGNZafgen Inc-0.28-4.26%
Data as of 6:30pm ET, 04/24/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$124.3M
Annual profit (last year)$23.3M
Net profit margin18.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Independent Director
Thomas Braxton King
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Campbell, California

Forecasts